1 pending office actions • 0 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Shandong Simcere Zaiming Biopharmaceutical Co. Ltd. has 1 pending office action assigned to 1 examiner. CHATTIN, AMY MARIE is the busiest examiner, with 1 pending matter.
The profile does not identify a technology area or art unit. Prosecution planning can therefore focus on the individual action and examiner relationship without relying on broader classification information.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| CHATTIN, AMY MARIE | 1 | 72.2% | +45.7% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18574812 | CD16 ANTIBODY AND USE THEREOF | CHATTIN, AMY MARIE | — |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18574812 | CD16 ANTIBODY AND USE THEREOF | CHATTIN, AMY MARIE | — | §112 | Non-Final OA | — | Pending | Dec 28, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialShandong Simcere Zaiming Biopharmaceutical Co. Ltd. has 1 pending office actions as of October 2026, spread across 0 art units and 1 examiners.
Amy Marie Chattin has the most, with 1 of Shandong Simcere Zaiming Biopharmaceutical Co. Ltd.'s pending office actions.
